Overview

Full Product Details

Author:   Yoshiyuki Yamaguchi
Publisher:   Springer Verlag, Japan
Imprint:   Springer Verlag, Japan
Edition:   1st ed. 2016
Dimensions:   Width: 15.50cm , Height: 2.50cm , Length: 23.50cm
Weight:   7.409kg
ISBN:  

9784431550303

ISBN 10:   4431550305
Pages:   358
Publication Date:   04 March 2016
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Part I Overview, History, Classification.- Chapter 1 Overview of Current Cancer Immunotherapy.- Part II BRMs and Crude Agents.- Chapter 2 Bacterial Preparations.- Chapter 3 Polysaccharides.- Chapter 4 BCG.- Part III Cytokines.- Chapter 5 αβ-T Cells.- Chapter 6 NKT Cell-Based Immunotherapy.- Chapter 7 Natural Killer Cells.- Chapter 8 γδ T Cell-Based Cancer Immunotherapy.- Chapter 9 Genetically engineered T cells.- Part IV Vaccine Therapy.- Chapter 10 Peptide Vaccine.- Chapter 11 Personalized Peptide Vaccine.- Chapter 12 WT1 Peptide Vaccine for the Treatment of Malignancies.- Chapter 13 Protein vaccine.- Chapter 14 Dendritic Cell-Based Vaccine for Cancer.- Part V Immunoadjuvants.- Chapter 15 CpG Motif.- Chapter 16 Pattern Recognition by Dendritic Cells and Its Application to Vaccine Adjuvant for Antitumor Immunotherapy.- Chapter 17 Novel Adjuvants.- Part VI Immunocheckpoints.- Chapter 18 Anti-CTLA-4 Ab.- Chapter 19 Anti-PD-1, PD-L1 Ab.- Chapter 20 Novel Targets of Immune Inhibitory and Stimulatory Co-signals.- Part VII Regulation of Immunosuppression.- Chapter 21 Regulatory T Cells.- Chapter 22 MDSC: Myeloid-Derived Suppressor Cells.- Part VIII Immune-Related Response Criteria and Guidance for Clinical Trials.- Chapter 23 Immune-Related Response Criteria and Guidance for Clinical Trials.- Part IX Personalized Immunotherapy.- Chapter 24 ersonalized cancer immunotherapy: Immune biomarkers and combination immunotherapy.

Reviews

“This book covers the history, current status and future of cancer immunotherapy. … The content of the book is simply exiting, well written and fully covering the problem. I strongly recommend this book to everybody working in the field.” (Jan Lakota, Neoplasma, Vol. 64 (1), 2017)

This book covers the history, current status and future of cancer immunotherapy. ... The content of the book is simply exiting, well written and fully covering the problem. I strongly recommend this book to everybody working in the field. (Jan Lakota, Neoplasma, Vol. 64 (1), 2017)

Author Information

Dr. Yoshiyuki Yamaguchi, MD, PhD, Professor, Department of Clinical Oncology, Kawasaki Medical School, Kurashiki, Japan  

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions